From: Development of a novel multi‑epitope vaccine against the pathogenic human polyomavirus V6/7 using reverse vaccinology
Tumor type
HPyV6 Positive
HPyV7 Positive
Reference
Laryngeal squamous cell carcinoma
14.3%
Not detected
[17]
Thymic epithelial tumors
62.2%
[18]
Cholangiocarcinoma
9.5%
45.2%
[19]